Novartis Stock To Go Ex-dividend Monday (NVS)

NEW YORK ( TheStreet) -- The ex-dividend date for Novartis (NYSE: NVS) is Monday, February 27, 2012. Owners of shares as of market close today will be eligible for a dividend of $2.09 per share. At a price of $57.57 as of 9:30 a.m. ET, the dividend yield is 3.7%.

The average volume for Novartis has been 2.4 million shares per day over the past 30 days. Novartis has a market cap of $135.13 billion and is part of the health care sector and drugs industry. Shares are up 0.8% year to date as of the close of trading on Thursday.

Novartis AG, through its subsidiaries, engages in the research, development, manufacture, and marketing of healthcare products worldwide. The company has a P/E ratio of 15.1, above the average drugs industry P/E ratio of 13.1 and below the S&P 500 P/E ratio of 17.7.

TheStreet Ratings rates Novartis as a buy. The company's strengths can be seen in multiple areas, such as its revenue growth, reasonable valuation levels, good cash flow from operations, largely solid financial position with reasonable debt levels by most measures and increase in stock price during the past year. We feel these strengths outweigh the fact that the company has had sub par growth in net income. You can view the full Novartis Ratings Report.

See our dividend calendar or top-yielding stocks list.
null

If you liked this article you might like

Novartis May Sell U.S. Generic Pill Business Amid Industry Struggles

Novartis May Sell U.S. Generic Pill Business Amid Industry Struggles

Teva Shares Fall as FDA OKs Another Generic Version of Multiple Sclerosis Drug

Teva Shares Fall as FDA OKs Another Generic Version of Multiple Sclerosis Drug

Axovant Shares Crater as CEO and President Both Resign

Axovant Shares Crater as CEO and President Both Resign

Generic Drug Makers Hurt By Latest Federal Government Budget

Generic Drug Makers Hurt By Latest Federal Government Budget